Sector
Westbridge invests £4m in DB Systems
Investment will be used to buy new equipment and potential add-on deals
Ardian's Riemser bolts on Intrapharm
Intrapharm had acquired Peckforton in 2014
Nordic Capital sells SEK 1.575bn of Thule shares
GP reduces holding to 29.3% after exit at SEK 105 per share
Transplant raises €1.5m from Kereon et al.
Funds to back commercial launch of organ transportation system
Agathos invests in EAT Communications
GP was founded earlier this year
Ovizio raises €8m from NSV et al.
VC's second foray in Belgian healthcare in recent months
Equistone divests Worldmark
Equistone first invested in the business in 2007
Isai et al. in $1.6m round for CodinGame
App aiming to hit 1 million user mark within one year
Inflexion carves out GFK's animal and crop health business
Buyout marks Inflexion's second carve-out in November
Keensight backs MBO for Vision-Box
Second MBO to involve the GP in last month
Albion injects £2m into Innovation Broking
Insurance broker plans to become regional actor in its segment
KKR leads $50m growth round for GetYourGuide
Investment is KKR’s third growth investment in Berlin
Holtzbrinck leads Caremondo's series-A
GP's current fund has €285m under management
HTGF backs Bjooli
Company was founded in 2014
MBO Partenaires exits 80% Profimo stake to Imerys Toiture
GP understood to have made 2x money on trade sale
Duke Street and Europa Capital exit Sandpiper
GPs had delisted the company in 2007 for ТЃ400m
Alven backs Frichti with €1m
VC currently investing from €120m fourth fund
Afinum acquires minority stake in Empolis
Firm's fourth fund closed on €280m in 2013
BC Partners buys 85% Cigierre stake in €300m SBO
Paladin Capital Partners and LVMH investment arm L Capital exit
N+1 sells 70% of Dinamia's portfolio to Access for €57.2m
Secondaries deal follows merger between N+1 and Dinamia in July
BC's Mergermarket Group buys C6 Intelligence
Bolt-on designed to bolster group's risk and regulatory portfolio
Vaaka adds six companies to Fysios platform
Buy-and-build group expands presence in Finland
Fintech: Buzz or substance?
Fintech is increasingly alluring to private equity, but is it all buzz and no substance?
LifeCare-backed Kuros raises CHF 5m extension
Company has been developing biomaterials since 2000